EMCDDA home page | www.emcdda.europa.eu

New regional reports

Our three new regional reports focus on emerging drug trends beyond EU borders. One report examines cross-border drug-related health and security threats in the Western Balkans, and the other two cover drug markets and emerging drug-related challenges in the eastern and southern European Neighbourhood Policy regions.

See the reports

Spotlight

EU solidarity with Ukraine

Lisbon Addictions 2022: presentations now available!

shows a close-up of a smartphone with someone selecting options on screen

Monitoring drug use in the digital age: studies in web surveys

EU Drug Markets: Cocaine

European Responses Guide

Penalties for drug law offences in Europe at a glance

Wastewater and drugs: a European multi.city study. Animated map of Europe with coloured bubbles over maps.

Wastewater analysis and drugs — a study

EU Drug Markets: Methamphetamiine

Elimination barometer on viral hepatitis among people who inject drugs in Europe

A happy small boy and a girl lying on a skateboard with arms outstreched as though flying. They are on the road, there are no cars and the sun is shining.

Prevention toolkit: your one-stop shop for EMCDDA prevention materials

Latest news

EMCDDA intensifies its cooperation with the Western Balkans and the European Neighbourhood Policy area

31.01.2023

New phase of collaboration between the EMCDDA and the Ukrainian Ministry of Health

30.01.2023

European Drugs Winter School, 13-24 february 2023, online, Displaced populations and drug-related issues

Bursaries for students from Latin American and Caribbean countries for the 2023 European Drugs Winter School

23.01.2023

Sweden takes over the EU presidency

13.01.2023

Season’s greetings and warm wishes for a peaceful 2023

19.12.2022

EMCDDA technical expert meeting on hexahydrocannabinol (HHC) and related cannabinoids

19.12.2022

All news

Party Panel: developing theory- and evidence-based health promotion in nightlife settings

Interactive timeline: EU4Monitoring Drugs (EU4MD) project highlights (2019-2022)

Quantitative and qualitative assessments of data quality within the European Web Survey on Drugs

Interactive timeline. 25 years of the EU Early Warning System (EWS

European Web Survey on Drugs: an overview of the project

cover of miniguide families and drugs: health and social responses

Families: responses miniguide

cover of miniguide homelessness and drugs: health and social responses

Homelessness: responses miniguide

Map of the Reitox network of national focal points

Reitox national focal points —2022 highlights

Combining web surveys and general population surveys to improve data on people who use drugs in France

cover of report Recreational use of nitrous oxide: a growing concern in Europe

Recreational use of nitrous oxide — a growing concern for Europe

All publications

European Drug Report 2022: Trends and Developments

EU Drug Markets: In-depth analysis

Cover for theof health and social responses

European Responses Guide

Prison and drugs in Europe

Wastewater analysis and drugs — a European study

European Web Survey on Drugs 2021: EU countries

European Prevention Curriculum handbook

An analysis of drugs in used syringes from sentinel European cities

Medical use of cannabis and cannabinoids

All publications

Events

Anniversary of the signing of EMCDDA regulation (1993)

08 Feb 2023

other

European Drugs Winter School (EDWS)

13 Feb 2023 to 24 Feb 2023

Online

Training

Sixty-sixth session of the Commission on Narcotic Drugs (CND)

13 Mar 2023 to 17 Mar 2023

Vienna, Austria

Meeting

European Drugs Summer School

26 Jun 2023 to 07 Jul 2023

Lisbon, Portugal

Training

All events

Videos

EMCDDA webinar recording: How wastewater monitoring can boost preparedness for new health threats

video cover — shows a doctor wearing blue gloves about to perform an autopsy

Drug-related deaths: why data matter to save lives

Futuristic image with the EMCDDA webinar title

EMCDDA webinar: Preparing for the future — applying a foresight approach in the drugs field

EMCDDA webinar: Drug consumption rooms in Europe

EMCDDA webinar, Wednesday 25 May 2022, 13.00-14.30 CET (Brussels): Knowing youth - digital platforms for decision making (ESPAD and beyond)

EMCDDA webinar: Knowing youth — digital platforms for decision making (ESPAD and beyond)

EMCDDA webinar: Workplaces and drugs – issues and challenges for the future

All videos

Data visualisations

Location of Euro-DEN hospital centres in Europe

Location of Euro-DEN Plus centres — November 2022

Location of drug consumption facilities in Europe, November 2019. The map shows a concentration of facilities in Belgium, the Netherlands, Germany, Switzerland and parts of Spain

Infographic. Location and number of drug consumption facilities throughout Europe

Some key cannabis prevalance use data for young adults in Europe. Less than 20% have used cannabis in the last year. There are wide variations between countries, from 2% to over 20%. More men report using than women. Frequency of use varies widely.

Cannabis use in the last year in Europe – young adults (15-34)

While last year cocaine use among young people is low, in many countries in Europe it is close to 3%.

Infographic: cocaine use in the last year in Europe – young adults (15-34)

Graphic shows a series of pie charts for cannabis, cocaine, MDMA and amphetamines, showing drug prevalance rates in the EU. Cannabis is the most used drug with 7.7% of adults having used it in the last year. Last year use for cocaine is 1.2%, MDMA is 0.9%

At a glance — estimates of drug use in the European Union (updated June 2022)

Main behavioural techniques used in prevention interventions in high-risk neighbourhoods: evidence of effectiveness, 2019

Availability of awareness-raising responses in the workplace in Europe ranges from Finland (58.3%) to Estonia (20.9%) with an EU27 average at 36.2%.

Availability of awareness-raising responses in the workplace to prevent substance use (e.g. smoking, alcohol or drugs)

Interventions in high-risk neighbourhoods: provision in European countries, 2019

Infographic: Has the COVID-19 pandemic had any impact on your drug use?